Correction: Synergistic drug combinations designed to fully suppress SARS-CoV-2 in the lung of COVID-19 patients.
Where this comes from
- Record sourced from PubMed, PMID 39636805.
- Also identified by DOI 10.1371/journal.pone.0315297 and PMC identifier 11620381.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0276751.].